2025-07-26 - Analysis Report
Okay, here's an analysis of iRobot Corp (IRBT) based on the provided data. The report is structured to present key metrics upfront, followed by more detailed analysis and finally a comprehensive summary.

## iRobot Corp (IRBT) Analysis

**Company Overview:** iRobot Corp. designs, builds, and sells robots for the home, including the Roomba vacuum cleaning robot.

**1. Performance vs. S&P 500 (VOO):**

*   **IRBT Cumulative Return:** -51.48%
*   **VOO Cumulative Return:** 99.66%
*   **Spread (IRBT - VOO):** -151.14%
*   **Relative Spread Percentile:** 2.0 (Indicates IRBT's underperformance is near the bottom of its historical range relative to VOO).

**Table: Alpha and Beta Analysis**

| Year       | CAGR     | MDD      | Alpha   | Beta  | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | 78.0%   | 57.1%   | 49.0%  | 0.1   | 2.4    |
| 2016-2018  | 106.0%  | 66.4%   | 88.0%  | 0.1   | 2.6    |
| 2017-2019  | -46.0%  | 66.4%   | -76.0% | 0.4   | 1.6    |
| 2018-2020  | -6.0%   | 66.4%   | -25.0% | 0.0   | 2.5    |
| 2019-2021  | -78.0%  | 58.4%   | -126.0%| -0.1  | 2.0    |
| 2020-2022  | -21.0%  | 72.0%   | -23.0% | -0.1  | 1.5    |
| 2021-2023  | -219.0% | 72.0%   | -237.0%| 0.0   | 1.2    |
| 2022-2024  | -99.0%  | 80.9%   | -124.0%| -0.1  | 0.2    |
| 2023-2025  | -31.0%  | 80.9%   | -82.0% | -0.2  | 0.1    |

**Analysis:**

*   IRBT has significantly underperformed the S&P 500 over the analyzed period. The large negative spread indicates substantial underperformance. The relative spread percentile confirms this, suggesting that the underperformance is historically significant.
*   The provided table highlights periods of high volatility and negative Alpha, indicating underperformance relative to the market, especially in recent years. The Beta values, while fluctuating, suggest that IRBT is generally more volatile than the market (Beta > 1). The Cap(B) shows a decreasing Market Capitalization

**2. Recent Price Action:**

*   **Current Price:** $4.88
*   **Last Market Data:** Price Change = -4.87% from previous close.
*   **5-Day Moving Average:** 4.902
*   **20-Day Moving Average:** 4.1605
*   **60-Day Moving Average:** 3.416

**Analysis:** The current price is below the 5-day moving average but above the 20 and 60-day moving averages, suggesting a possible short-term pullback but still exhibiting a longer-term upward trend. The significant price change in the last market data indicates recent volatility, likely driven by news or market sentiment.

**3. Technical Indicators and Outlook:**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 64.04 (Approaching overbought territory)
*   **PPO:** 1.19 (Positive, indicating bullish momentum)
*   **Hybrid Signal:** Cautious Buy (Based on cash and MRI)
*   **Recent (20-Day) Relative Spread Change:** -0.5 (Short-term downward trend)
*   **Expected Return:** -4507.9% (Extremely negative, indicating potential long-term underperformance relative to the S&P 500)

**Analysis:** The MRI suggests a low-risk market environment. However, the RSI is nearing overbought conditions. The PPO indicates positive momentum, but the negative change in relative spread and extremely negative expected return are major concerns. The "Caution" signal reflects the conflicting signals.

**4. Recent News & Significant Events:**

*   **[2025-07-22]:** Major business developments, regulatory changes, or market events impacting iRobot.
*   **[2025-07-23]:** Analyst discussions on performance and outlook.
*   **[2025-07-24]:** Notable stock volatility due to news, earnings, or executive actions.
*   **[2025-07-25]:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests increased scrutiny and volatility surrounding iRobot. Investors should closely monitor company announcements and analyst reports.

**5. Recent Earnings Analysis:**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-05-06 | -2.84  | 0.10 B$   |
| 2024-11-06 | -0.21  | 0.19 B$   |
| 2024-08-07 | -2.41  | 0.17 B$   |
| 2024-05-08 | 0.31   | 0.15 B$   |
| 2025-05-06 | 0.31   | 0.15 B$   |

**Analysis:** The company's recent earnings have been mixed. The EPS has been inconsistent with some periods of significant losses. Revenue has also fluctuated.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $0.10B   | 20.00%         |
| 2024-12-31   | $0.17B   | 9.54%          |
| 2024-09-30   | $0.19B   | 32.25%         |
| 2024-06-30   | $0.17B   | 16.51%         |
| 2024-03-31   | $0.15B   | 24.07%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE           |
|--------------|----------|---------------|
| 2025-03-31   | $-0.00B  | 11005.42%     |
| 2024-12-31   | $0.06B   | -125.91%      |
| 2024-09-30   | $0.15B   | -4.24%        |
| 2024-06-30   | $0.15B   | -47.39%       |
| 2024-03-31   | $0.20B   | 4.22%         |

**Analysis:**  Revenue has fluctuated but generally shows moderate levels. Profit margins have varied significantly. Of particular concern is the negative equity reported for the quarter ending 2025-03-31. Also concerning is the huge fluctuation of ROE over the recent time periods.

**7. Comprehensive Summary:**

iRobot Corp. (IRBT) is facing significant challenges. Its stock has dramatically underperformed the S&P 500, and its financial performance has been inconsistent. Recent earnings reports show fluctuating revenue and mixed profitability. The very large negative Expected Return suggests that iRobot is forecast to massively underperform the S&P 500 going forward. While the MRI indicates a low-risk market environment, technical indicators are mixed, and recent news suggests potential volatility. The negative equity raises concerns about the company's financial stability.

**Recommendation:**

Based on the current data, a cautious approach to investing in IRBT is warranted. Investors should closely monitor company announcements, analyst reports, and financial performance. The company faces several risks and uncertainties, and its ability to turn around its performance is uncertain. Further investigation into the cause of the negative equity and the company's plans to address it is warranted.
